Device Trial Radar · NCT07915401
Bacterial Reduction in Apical Root Canals After Bioceramic or Calcium Hydroxide Medicament
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Jun 12, 2026
Primary completion
Sep 28, 2026
Study completion Sep 28, 2026
Sponsor
- Lead sponsor
- Hasanuddin UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 4, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn whether a bioceramic root canal medicament reduces bacteria better than calcium hydroxide in adults with asymptomatic apical periodontitis (a long-standing infection at the tip of the tooth root that does not cause pain) in upper front teeth. The main question it aims to answer is: Does the bioceramic medicament (Bio-C Temp) lower the amount of bacteria in the end portion (apical third) of the root canal more than calcium hydroxide (UltraCal XS)? Researchers will compare the bioceramic medicament with calcium hydroxide to see which one leaves fewer bacteria in the root canal after 14 days. Participants will: Receive standard root canal cleaning and shaping on one upper front tooth Have bacterial samples taken from the root canal before and after cleaning Be randomly assigned to receive either the bioceramic or the calcium hydroxide medicament inside the root canal for 14 days Return after 14 days for a final bacterial sample before the root canal treatment is continued The amount of bacteria in each sample will be measured in the laboratory using quantitative polymerase chain reaction (qPCR).
Conditions
- Asymptomatic Apical Periodontitis
Interventions
Bio-C TempDevice
A ready-to-use, premixed bioceramic (calcium silicate-based) intracanal medicament (Bio-C Temp, Angelus). After chemomechanical preparation with ProTaper Gold files and 2.5% NaOCl irrigation activated by passive ultrasonic irrigation, the medicament was delivered into the root canal to the working length using the manufacturer's syringe and tip. The canal access was sealed with a sterile cotton pellet and temporary restoration, and the medicament was left in place for 14 days. At the second visit, the medicament was removed with sterile distilled water and the master apical file before final bacterial sampling (S3).
Calcium hydroxide medicamentDevice
A premixed aqueous calcium hydroxide paste intracanal medicament (UltraCal XS, Ultradent). After chemomechanical preparation with ProTaper Gold files and 2.5% NaOCl irrigation activated by passive ultrasonic irrigation, the medicament was delivered into the root canal to the working length using the manufacturer's syringe and tip. The canal access was sealed with a sterile cotton pellet and temporary restoration, and the medicament was left in place for 14 days. At the second visit, the medicament was removed with sterile distilled water and the master apical file before final bacterial sampling (S3).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Bacterial Load in the Apical Third of the Root CanalTime frame: Baseline before root canal preparation (S1, Day 0), after preparation and ultrasonic activation (S2, Day 0), and after 14 days of intracanal medication (S3, Day 14)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hasanuddin University Dental Hospital (Rumah Sakit Gigi Dan Mulut Pendidikan Universitas Hasanuddin)
Makassar, South Sulawesi, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.